Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$637M |
| 2 |
Weyerhaeuser
WY
|
+$340M |
| 3 |
IQVIA
IQV
|
+$132M |
| 4 |
Halliburton
HAL
|
+$123M |
| 5 |
Dover
DOV
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.68B |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$708M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$460M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$293M |
| 5 |
Gilead Sciences
GILD
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Healthcare | 5.12% |
| 3 | Financials | 4.53% |
| 4 | Consumer Discretionary | 4.09% |
| 5 | Communication Services | 3.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UMPQ
2601
DELISTED
Umpqua Holdings Corp
UMPQ
| $1.48M | ﹤0.01% |
75,576
-3,301
| -4% | -$60.1K |
|
|
MSFG
2602
DELISTED
MainSource Financial Group Inc
MSFG
| $1.48M | ﹤0.01% |
41,136
+41,118
| +228,433% | +$1.39M |
|
2603
PUT
FirstEnergy
FE
$27.9B
| $1.47M | ﹤0.01% |
47,800
+10,700
| +29% | +$337K |
|
2604
W.R. Berkley
WRB
$26.5B
| $1.47M | ﹤0.01% |
74,334
+880
| +1% | +$17.6K |
|
|
MIME
2605
DELISTED
Mimecast Limited
MIME
| $1.47M | ﹤0.01% |
51,671
+17,751
| +52% | +$488K |
|
2606
Tenet Healthcare
THC
$20.4B
| $1.47M | ﹤0.01% |
89,278
-40,987
| -31% | -$695K |
|
2607
Ecopetrol
EC
$33.5B
| $1.46M | ﹤0.01% |
154,100
-32,900
| -18% | -$304K |
|
2608
iShares Select Dividend ETF
DVY
$23.8B
| $1.46M | ﹤0.01% |
15,598
+8,996
| +136% | +$832K |
|
2609
REX American Resources
REX
$1.46B
| $1.46M | ﹤0.01% |
93,312
-12,762
| -12% | -$200K |
|
2610
TransUnion
TRU
$15.7B
| $1.46M | ﹤0.01% |
30,891
+9,557
| +45% | +$437K |
|
2611
MDU Resources
MDU
$4.2B
| $1.46M | ﹤0.01% |
147,778
+116,125
| +367% | +$1.16M |
|
2612
Descartes Systems
DSGX
$6.63B
| $1.46M | ﹤0.01% |
53,300
| – | – |
|
2613
iShares Russell 1000 Growth ETF
IWF
$127B
| $1.46M | ﹤0.01% |
46,616
+37,224
| +396% | +$1.14M |
|
|
ICPT
2614
PUT
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.46M | ﹤0.01% |
25,100
+24,000
| +2,182% | +$2.59M |
|
2615
CALL
Smith & Wesson
SWBI
$670M
| $1.45M | ﹤0.01% |
123,725
+14,831
| +14% | +$209K |
|
2616
PUT
Designer Brands
DBI
$336M
| $1.45M | ﹤0.01% |
67,400
+29,300
| +77% | +$539K |
|
2617
CALL
Fluor
FLR
$7.2B
| $1.45M | ﹤0.01% |
34,400
-133,400
| -79% | -$5.53M |
|
|
FDC
2618
DELISTED
First Data Corporation
FDC
| $1.45M | ﹤0.01% |
80,247
-128,450
| -62% | -$2.34M |
|
2619
RenaissanceRe
RNR
$13.4B
| $1.45M | ﹤0.01% |
10,695
-4,922
| -32% | -$693K |
|
2620
CALL
Quest Diagnostics
DGX
$25.8B
| $1.44M | ﹤0.01% |
+15,400
| New | +$1.63M |
|
|
CUDA
2621
DELISTED
Barracuda Networks, Inc.
CUDA
| $1.44M | ﹤0.01% |
59,484
+34,528
| +138% | +$812K |
|
2622
CALL
Calumet Specialty Products
CLMT
$3.62B
| $1.44M | ﹤0.01% |
172,400
+170,300
| +8,110% | +$1.06M |
|
2623
PUT
Jacobs Solutions
J
$16.8B
| $1.44M | ﹤0.01% |
29,862
+29,378
| +6,070% | +$1.31M |
|
2624
PUT
Terex
TEX
$7.55B
| $1.44M | ﹤0.01% |
31,900
+16,600
| +108% | +$657K |
|
2625
Interactive Brokers
IBKR
$39.5B
| $1.43M | ﹤0.01% |
127,420
-67,424
| -35% | -$688K |
|
Similar funds
Barclays's Q3 2017 Portfolio in Review
As of Q3 2017, Barclays held 7,380 positions worth $97.1B, up 4% from $93.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays's Q3 2017 filing shows 424 new, 3,249 increased, 2,816 reduced and 405 closed positions. Its largest new stake was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M. The largest sale was Invesco QQQ Trust, an estimated $3.68B.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, up from 6.1% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2017 buy was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $637M increase.
- Barclays's biggest Q3 2017 reduction was Invesco QQQ Trust, cutting an estimated $3.68B.
- Barclays fully exited Reynolds American Inc in Q3 2017, selling an estimated $293M.
- Barclays's ten largest holdings make up 29% of its $97.1B portfolio in Q3 2017.
- Barclays opened 424 new positions and closed 405 in Q3 2017.
- Barclays's portfolio value rose 4% quarter-over-quarter to $97.1B.
Based on Barclays's 13F filing for Q3 2017, filed 14 Nov 2017.